IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodies.

Saved in:
Bibliographic Details
Title: IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodies.
Authors: Moreau TRJ; Université Paris Cité, Paris, France.; CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques UMR8601, Paris, France.; Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France., Bondet V; Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France., Veldkamp SR; Center for Translational Immunology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.; Pediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands., Bletry D; Université Paris Cité, Paris, France.; CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques UMR8601, Paris, France., Ramos J; Université Paris Cité, Paris, France.; General Paediatrics, Infectious Disease and Internal Medicine Department, Robert Debré Hospital, AP-HP, Paris, France.; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France., Villain E; Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France., Ouldali N; Université Paris Cité, Paris, France.; General Paediatrics, Infectious Disease and Internal Medicine Department, Robert Debré Hospital, AP-HP, Paris, France.; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France., Alyanakan MA; Department of Biological Immunology, Necker-Enfants Malades Hospital, Paris, France., Bodemer C; Université Paris Cité, Paris, France.; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), Necker-Enfants Malades Hospital (AP-HP5, Imagine Institute, INSERM), Paris, France., Bonhomme S; CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques UMR8601, Paris, France., Dingulu G; Université Paris Cité, Paris, France.; General Paediatrics, Infectious Disease and Internal Medicine Department, Robert Debré Hospital, AP-HP, Paris, France.; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France., Dumaine C; Université Paris Cité, Paris, France.; General Paediatrics, Infectious Disease and Internal Medicine Department, Robert Debré Hospital, AP-HP, Paris, France.; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France., Duong NB; Université Paris Cité, Paris, France.; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France.; Paediatric Haematology-Immunology and Rheumatology Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France., Charuel JL; Department of Immunology, Sorbonne Université, La Pitié-Salpêtrière Hospital (AP-HP), Paris, France., Eveillard LA; Université Paris Cité, Paris, France.; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France.; Paediatric Haematology-Immunology and Rheumatology Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France., Fournier B; Université Paris Cité, Paris, France.; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France.; Paediatric Haematology-Immunology and Rheumatology Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France., Frémond ML; Université Paris Cité, Paris, France.; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France.; Paediatric Haematology-Immunology and Rheumatology Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France.; Laboratory of Neurogenetics and Neuroinflammation, Institut Imagine, INSERM U1163, Paris, France., Isapof A; Centre de Référence des Maladies Neuromusculaires Nord/Est/Ile de France, Service de Neuropédiatrie, Hôpital Trousseau, Paris, France., Quartier P; Université Paris Cité, Paris, France.; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France.; Paediatric Haematology-Immunology and Rheumatology Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France., Vinit C; Université Paris Cité, Paris, France.; General Paediatrics, Infectious Disease and Internal Medicine Department, Robert Debré Hospital, AP-HP, Paris, France.; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France.; Paediatric Haematology-Immunology and Rheumatology Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France., Welfringer-Morin A; Université Paris Cité, Paris, France.; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), Necker-Enfants Malades Hospital (AP-HP5, Imagine Institute, INSERM), Paris, France., van Royen-Kerkhof A; Pediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands., van Wijk F; Center for Translational Immunology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.; Pediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands., Gitiaux C; Université Paris Cité, Paris, France.; CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques UMR8601, Paris, France.; Department of Paediatric Neurophysiology, Reference Center for Neuromuscular Diseases AP-HP, Necker-Enfants Malades Hospital, Paris, France., Jansen M; Pediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands., Melki I; Université Paris Cité, Paris, France.; General Paediatrics, Infectious Disease and Internal Medicine Department, Robert Debré Hospital, AP-HP, Paris, France.; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France.; Department of General Pediatrics, Trousseau Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France., Duffy D; Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France., Bader-Meunier B; Reference centre for inflammatory rheumatism, AutoImmune disease and Systemic interferonopathies in childrEn (RAISE), Paris, France.; Paediatric Haematology-Immunology and Rheumatology Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France., Rodero MP; Université Paris Cité, Paris, France.; CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques UMR8601, Paris, France.
Corporate Authors: Dutch Juvenile Myositis Consortium
Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2026 Jan 08; Vol. 65 (1).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1462-0332
DOI:10.1093/rheumatology/keaf549